Holmes Robert O, Tavee Jinny
Walter Reed Army Medical Center, Silver Spring, MD 20910, USA.
Mil Med. 2008 Jul;173(7):708-10. doi: 10.7205/milmed.173.7.708.
Following the 2004 ban of ephedra, which was linked to several cases of stroke and myocardial infarction, manufacturers have marketed "ephedra-free" weight loss products that include the active ingredient synephrine. Despite the lack of data on safety and efficacy, synephrine is touted by its promoters as a "safe" alternative to ephedra and is often combined with caffeine, as in the supplement Xenadrine-EFX. We report a case of left middle cerebral artery vasopasm and stroke in a young healthy patient in the setting of Xenadrine-EFX use.
2004年麻黄碱被禁，此前它与多起中风和心肌梗死病例有关，此后制造商开始推销不含麻黄碱的减肥产品，这些产品含有活性成分辛弗林。尽管缺乏关于安全性和有效性的数据，但辛弗林的推广者宣称它是麻黄碱的“安全”替代品，并且常与咖啡因混合使用，比如在Xenadrine-EFX补充剂中。我们报告了一名年轻健康患者在使用Xenadrine-EFX时发生左大脑中动脉血管痉挛和中风的病例。
